Literature DB >> 17299439

CHARGE syndrome: an update.

Damien Sanlaville1, Alain Verloes.   

Abstract

CHARGE syndrome is a rare, usually sporadic autosomal dominant disorder due in 2/3 of cases to mutations within the CHD7 gene. The clinical definition has evolved with time. The 3C triad (Coloboma-Choanal atresia-abnormal semicircular Canals), arhinencephaly and rhombencephalic dysfunctions are now considered the most important and constant clues to the diagnosis. We will discuss here recent aspects of the phenotypic delineation of CHARGE syndrome and highlight the role of CHD7 in its pathogeny. We review available data on its molecular pathology as well as cytogenetic and molecular evidences for genetic heterogeneity within CHARGE syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17299439     DOI: 10.1038/sj.ejhg.5201778

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  81 in total

Review 1.  Cranial neural crest cells on the move: their roles in craniofacial development.

Authors:  Dwight R Cordero; Samantha Brugmann; Yvonne Chu; Ruchi Bajpai; Maryam Jame; Jill A Helms
Journal:  Am J Med Genet A       Date:  2010-12-10       Impact factor: 2.802

2.  Kismet/CHD7 regulates axon morphology, memory and locomotion in a Drosophila model of CHARGE syndrome.

Authors:  David J Melicharek; Laura C Ramirez; Sukhdeep Singh; Rhea Thompson; Daniel R Marenda
Journal:  Hum Mol Genet       Date:  2010-08-17       Impact factor: 6.150

Review 3.  Chromodomain proteins in development: lessons from CHARGE syndrome.

Authors:  W S Layman; E A Hurd; D M Martin
Journal:  Clin Genet       Date:  2010-04-08       Impact factor: 4.438

4.  CHD7 and retinoic acid signaling cooperate to regulate neural stem cell and inner ear development in mouse models of CHARGE syndrome.

Authors:  Joseph A Micucci; Wanda S Layman; Elizabeth A Hurd; Ethan D Sperry; Sophia F Frank; Mark A Durham; Donald L Swiderski; Jennifer M Skidmore; Peter C Scacheri; Yehoash Raphael; Donna M Martin
Journal:  Hum Mol Genet       Date:  2013-09-10       Impact factor: 6.150

5.  Prevalence of genetic testing in CHARGE syndrome.

Authors:  Timothy S Hartshorne; Kasee K Stratton; Conny M A van Ravenswaaij-Arts
Journal:  J Genet Couns       Date:  2010-09-28       Impact factor: 2.537

6.  Clival Malformations in CHARGE Syndrome.

Authors:  E S Mahdi; M T Whitehead
Journal:  AJNR Am J Neuroradiol       Date:  2018-04-05       Impact factor: 3.825

7.  Novel Frameshift CHD7 Mutation Related to CHARGE Syndrome.

Authors:  E Martínez-Quintana; F Rodríguez-González; P Garay-Sánchez; A Tugores
Journal:  Mol Syndromol       Date:  2013-10-04

8.  CHD7 regulates cardiovascular development through ATP-dependent and -independent activities.

Authors:  Shun Yan; Rassarin Thienthanasit; Dongquan Chen; Erik Engelen; Joanna Brühl; David K Crossman; Robert Kesterson; Qin Wang; Karim Bouazoune; Kai Jiao
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-30       Impact factor: 11.205

9.  Ocular coloboma and dorsoventral neuroretinal patterning defects in Lrp6 mutant eyes.

Authors:  Cheng-Ji Zhou; Andrei Molotkov; Lanying Song; Yunhong Li; David E Pleasure; Samuel J Pleasure; Ya-Zhou Wang
Journal:  Dev Dyn       Date:  2008-12       Impact factor: 3.780

10.  Kallmann syndrome.

Authors:  Catherine Dodé; Jean-Pierre Hardelin
Journal:  Eur J Hum Genet       Date:  2008-11-05       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.